MXPA99011318A - Liquid antimicrobial cleansing compositions - Google Patents
Liquid antimicrobial cleansing compositionsInfo
- Publication number
- MXPA99011318A MXPA99011318A MXPA/A/1999/011318A MX9911318A MXPA99011318A MX PA99011318 A MXPA99011318 A MX PA99011318A MX 9911318 A MX9911318 A MX 9911318A MX PA99011318 A MXPA99011318 A MX PA99011318A
- Authority
- MX
- Mexico
- Prior art keywords
- surfactants
- skin
- antimicrobial
- class
- rinsing
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 146
- 230000000845 anti-microbial Effects 0.000 title claims description 59
- 239000007788 liquid Substances 0.000 title description 20
- 210000003491 Skin Anatomy 0.000 claims description 83
- 239000003795 chemical substances by application Substances 0.000 claims description 50
- 239000004094 surface-active agent Substances 0.000 claims description 41
- 239000003945 anionic surfactant Substances 0.000 claims description 38
- 241000894006 Bacteria Species 0.000 claims description 31
- 238000004140 cleaning Methods 0.000 claims description 31
- 239000003381 stabilizer Substances 0.000 claims description 28
- 230000003020 moisturizing Effects 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 125000002091 cationic group Chemical group 0.000 claims description 13
- 229920000642 polymer Polymers 0.000 claims description 11
- 239000004264 Petrolatum Substances 0.000 claims description 10
- 229940066842 Petrolatum Drugs 0.000 claims description 10
- 235000019271 petrolatum Nutrition 0.000 claims description 10
- 150000007524 organic acids Chemical group 0.000 claims description 9
- 239000000080 wetting agent Substances 0.000 claims description 8
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims description 7
- 230000000694 effects Effects 0.000 claims description 7
- 229960003500 triclosan Drugs 0.000 claims description 6
- WCOXQTXVACYMLM-UHFFFAOYSA-N 2,3-bis(12-hydroxyoctadecanoyloxy)propyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC(O)CCCCCC)COC(=O)CCCCCCCCCCC(O)CCCCCC WCOXQTXVACYMLM-UHFFFAOYSA-N 0.000 claims description 5
- 206010000496 Acne Diseases 0.000 claims description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N Lauric acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 4
- 239000004599 antimicrobial Substances 0.000 claims description 4
- 230000002708 enhancing Effects 0.000 claims description 3
- 239000005639 Lauric acid Substances 0.000 claims description 2
- 229920000831 ionic polymer Polymers 0.000 claims description 2
- 229960004889 salicylic acid Drugs 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims 2
- LQZZUXJYWNFBMV-UHFFFAOYSA-N Dodecanol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 claims 1
- 241001367079 Una Species 0.000 abstract 2
- -1 Chlorbutanol Glycerylurea Chemical compound 0.000 description 62
- 239000002253 acid Substances 0.000 description 30
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 24
- 125000004432 carbon atoms Chemical group C* 0.000 description 19
- 239000011734 sodium Substances 0.000 description 17
- 125000000217 alkyl group Chemical group 0.000 description 16
- 235000014113 dietary fatty acids Nutrition 0.000 description 16
- 239000000194 fatty acid Substances 0.000 description 16
- 239000003921 oil Substances 0.000 description 16
- 235000019198 oils Nutrition 0.000 description 16
- 229910052708 sodium Inorganic materials 0.000 description 16
- 239000004615 ingredient Substances 0.000 description 15
- 239000000463 material Substances 0.000 description 15
- 125000000129 anionic group Chemical group 0.000 description 14
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 14
- 150000004665 fatty acids Chemical class 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 12
- 150000001768 cations Chemical class 0.000 description 12
- 230000001105 regulatory Effects 0.000 description 12
- 150000007513 acids Chemical class 0.000 description 11
- AKEJUJNQAAGONA-UHFFFAOYSA-N Sulfur trioxide Chemical compound O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 description 10
- 239000011777 magnesium Substances 0.000 description 10
- 239000000377 silicon dioxide Substances 0.000 description 10
- 239000004166 Lanolin Substances 0.000 description 9
- 229940039717 Lanolin Drugs 0.000 description 9
- 230000000844 anti-bacterial Effects 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 235000019388 lanolin Nutrition 0.000 description 9
- 229910052749 magnesium Inorganic materials 0.000 description 9
- 235000001055 magnesium Nutrition 0.000 description 9
- 239000011780 sodium chloride Substances 0.000 description 9
- FYYHWMGAXLPEAU-UHFFFAOYSA-N magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 8
- 239000011591 potassium Substances 0.000 description 8
- 229910052700 potassium Inorganic materials 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 239000000344 soap Substances 0.000 description 8
- ZBCBWPMODOFKDW-UHFFFAOYSA-N Diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 7
- 208000006641 Skin Disease Diseases 0.000 description 7
- XOAAWQZATWQOTB-UHFFFAOYSA-N Taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 7
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Tris Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 7
- 230000032683 aging Effects 0.000 description 7
- HZAXFHJVJLSVMW-UHFFFAOYSA-N ethanolamine Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 7
- 150000002632 lipids Chemical class 0.000 description 7
- 229920001296 polysiloxane Polymers 0.000 description 7
- 230000001052 transient Effects 0.000 description 7
- 241000192125 Firmicutes Species 0.000 description 6
- 229920001083 Polybutene Polymers 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 description 6
- 239000011707 mineral Chemical class 0.000 description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 5
- 125000003342 alkenyl group Chemical group 0.000 description 5
- 230000000875 corresponding Effects 0.000 description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 235000005985 organic acids Nutrition 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 235000021317 phosphate Nutrition 0.000 description 5
- 238000006277 sulfonation reaction Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 239000001993 wax Substances 0.000 description 5
- 210000000170 Cell Membrane Anatomy 0.000 description 4
- CXQXSVUQTKDNFP-UHFFFAOYSA-N Simethicone Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 125000002252 acyl group Chemical class 0.000 description 4
- 150000008051 alkyl sulfates Chemical class 0.000 description 4
- 239000004927 clay Substances 0.000 description 4
- 229910052570 clay Inorganic materials 0.000 description 4
- 235000012343 cottonseed oil Nutrition 0.000 description 4
- 229940008099 dimethicone Drugs 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-N malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000002736 nonionic surfactant Substances 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 description 4
- 239000008158 vegetable oil Chemical class 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- BVDRUCCQKHGCRX-UHFFFAOYSA-N 2,3-dihydroxypropyl formate Chemical compound OCC(O)COC=O BVDRUCCQKHGCRX-UHFFFAOYSA-N 0.000 description 3
- 210000002421 Cell Wall Anatomy 0.000 description 3
- 206010009866 Cold sweat Diseases 0.000 description 3
- 150000001336 alkenes Chemical class 0.000 description 3
- 125000005466 alkylenyl group Chemical group 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000003750 conditioning Effects 0.000 description 3
- 239000002385 cottonseed oil Substances 0.000 description 3
- 230000000249 desinfective Effects 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 238000005187 foaming Methods 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- 235000010446 mineral oil Nutrition 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000003549 soybean oil Substances 0.000 description 3
- 235000012424 soybean oil Nutrition 0.000 description 3
- 238000005670 sulfation reaction Methods 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical class CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N Adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N Anethole Natural products COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 241000218645 Cedrus Species 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 240000002268 Citrus limon Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 240000007170 Cocos nucifera Species 0.000 description 2
- ZIUSSTSXXLLKKK-HWUZOJPISA-N Curcumin Natural products C1=C(O)C(OC)=CC(\C=C\C(\O)=C/C(=O)/C=C/C=2C=C(OC)C(O)=CC=2)=C1 ZIUSSTSXXLLKKK-HWUZOJPISA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 208000001840 Dandruff Diseases 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N Eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- JFCQEDHGNNZCLN-UHFFFAOYSA-N Glutaric acid Chemical compound OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 2
- 206010020400 Hostility Diseases 0.000 description 2
- 229960004873 LEVOMENTHOL Drugs 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N Malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 229940041616 Menthol Drugs 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N Methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- DHNRXBZYEKSXIM-UHFFFAOYSA-N Methylchloroisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 2
- DHVLDKHFGIVEIP-UHFFFAOYSA-N Methyldibromo glutaronitrile Chemical compound BrCC(Br)(C#N)CCC#N DHVLDKHFGIVEIP-UHFFFAOYSA-N 0.000 description 2
- FQTLCLSUCSAZDY-QKXCFHHRSA-N Nerolidol Natural products CC(C)=CCC\C(C)=C/CC[C@](C)(O)C=C FQTLCLSUCSAZDY-QKXCFHHRSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N Palmitic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N Phenethyl alcohol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N Phosphorus pentoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- BTSZTGGZJQFALU-UHFFFAOYSA-N Piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene (PE) Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N Resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- 206010039447 Salmonellosis Diseases 0.000 description 2
- KSAVQLQVUXSOCR-UHFFFAOYSA-M Sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 2
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-L Sulphite Chemical compound [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 2
- 229960003080 Taurine Drugs 0.000 description 2
- ICUTUKXCWQYESQ-UHFFFAOYSA-N Triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 2
- HWKQNAWCHQMZHK-UHFFFAOYSA-N Trolnitrate Chemical compound [O-][N+](=O)OCCN(CCO[N+]([O-])=O)CCO[N+]([O-])=O HWKQNAWCHQMZHK-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000003082 abrasive agent Substances 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid Chemical class OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminum Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000003212 astringent agent Substances 0.000 description 2
- 244000052616 bacterial pathogens Species 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 238000001595 flow curve Methods 0.000 description 2
- 229910021485 fumed silica Inorganic materials 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 230000001965 increased Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 229940099690 malic acid Drugs 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 230000000813 microbial Effects 0.000 description 2
- 239000004200 microcrystalline wax Substances 0.000 description 2
- 235000019808 microcrystalline wax Nutrition 0.000 description 2
- HGASFNYMVGEKTF-UHFFFAOYSA-N octan-1-ol;hydrate Chemical compound O.CCCCCCCCO HGASFNYMVGEKTF-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N oxane Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 230000001717 pathogenic Effects 0.000 description 2
- 244000052769 pathogens Species 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 229950001046 piroctone Drugs 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000002335 preservative Effects 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 150000003385 sodium Chemical group 0.000 description 2
- RTVVXRKGQRRXFJ-UHFFFAOYSA-N sodium;2-sulfobutanedioic acid Chemical compound [Na].OC(=O)CC(C(O)=O)S(O)(=O)=O RTVVXRKGQRRXFJ-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000001384 succinic acid Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 150000003871 sulfonates Chemical class 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissues Anatomy 0.000 description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 2
- 230000000699 topical Effects 0.000 description 2
- 229960001325 triclocarban Drugs 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 239000004711 α-olefin Substances 0.000 description 2
- CRPUJAZIXJMDBK-DTWKUNHWSA-N (+)-camphene Chemical compound C1C[C@@H]2C(=C)C(C)(C)[C@H]1C2 CRPUJAZIXJMDBK-DTWKUNHWSA-N 0.000 description 1
- XMGQYMWWDOXHJM-UHFFFAOYSA-N (+-)-(RS)-limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- LDVVMCZRFWMZSG-OLQVQODUSA-N (3aR,7aS)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)Cl)C(=O)[C@H]21 LDVVMCZRFWMZSG-OLQVQODUSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- DCSCXTJOXBUFGB-JGVFFNPUSA-N (R)-(+)-Verbenone Natural products CC1=CC(=O)[C@@H]2C(C)(C)[C@H]1C2 DCSCXTJOXBUFGB-JGVFFNPUSA-N 0.000 description 1
- DCSCXTJOXBUFGB-SFYZADRCSA-N (R)-(+)-verbenone Chemical compound CC1=CC(=O)[C@H]2C(C)(C)[C@@H]1C2 DCSCXTJOXBUFGB-SFYZADRCSA-N 0.000 description 1
- URLJMZWTXZTZRR-UHFFFAOYSA-N (tetradecyloxy)sulfonic acid Chemical class CCCCCCCCCCCCCCOS(O)(=O)=O URLJMZWTXZTZRR-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N 1,8-cineol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- DBHODFSFBXJZNY-UHFFFAOYSA-N 2,4-Dichlorobenzyl alcohol Chemical compound OCC1=CC=C(Cl)C=C1Cl DBHODFSFBXJZNY-UHFFFAOYSA-N 0.000 description 1
- DUFKCOQISQKSAV-UHFFFAOYSA-N 2-(2-hydroxypropoxy)propan-1-ol Chemical group CC(O)COC(C)CO DUFKCOQISQKSAV-UHFFFAOYSA-N 0.000 description 1
- SUZRRICLUFMAQD-UHFFFAOYSA-N 2-(methylamino)ethanesulfonic acid Chemical compound CNCCS(O)(=O)=O SUZRRICLUFMAQD-UHFFFAOYSA-N 0.000 description 1
- LLEMOWNGBBNAJR-UHFFFAOYSA-N 2-Phenylphenol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 description 1
- FKMHSNTVILORFA-UHFFFAOYSA-N 2-[2-(2-dodecoxyethoxy)ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCO FKMHSNTVILORFA-UHFFFAOYSA-N 0.000 description 1
- RGPBUVUVZKQNHD-MDZDMXLPSA-N 2-[2-[3,5-bis(2-hydroxyethoxy)oxolan-2-yl]-2-(2-hydroxyethoxy)ethoxy]ethyl (E)-octadec-9-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCCOCC(OCCO)C1OC(OCCO)CC1OCCO RGPBUVUVZKQNHD-MDZDMXLPSA-N 0.000 description 1
- NCKMMSIFQUPKCK-UHFFFAOYSA-N 2-benzyl-4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1CC1=CC=CC=C1 NCKMMSIFQUPKCK-UHFFFAOYSA-N 0.000 description 1
- COVGKJSMQVFLDP-UHFFFAOYSA-N 2-bromo-3-hexylphenol Chemical compound CCCCCCC1=CC=CC(O)=C1Br COVGKJSMQVFLDP-UHFFFAOYSA-N 0.000 description 1
- GALVARIIMUNUQL-UHFFFAOYSA-N 2-chloroacetamide;methanamine Chemical compound NC.NC(=O)CCl GALVARIIMUNUQL-UHFFFAOYSA-N 0.000 description 1
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- YAGGXOABVFEQPJ-UHFFFAOYSA-N 2-phenylphenol;sodium Chemical compound [Na].[Na].OC1=CC=CC=C1C1=CC=CC=C1 YAGGXOABVFEQPJ-UHFFFAOYSA-N 0.000 description 1
- XPNKJGMHGPTELE-UHFFFAOYSA-N 3-hexoxyphenol Chemical compound CCCCCCOC1=CC=CC(O)=C1 XPNKJGMHGPTELE-UHFFFAOYSA-N 0.000 description 1
- LVHWGLAHVJJCIT-UHFFFAOYSA-N 4-butylphenol;4-propylphenol Chemical compound CCCC1=CC=C(O)C=C1.CCCCC1=CC=C(O)C=C1 LVHWGLAHVJJCIT-UHFFFAOYSA-N 0.000 description 1
- LYOFHYLVYHTGBK-UHFFFAOYSA-N 4-chloro-1,5-dimethylcyclohexa-2,4-dien-1-ol Chemical compound CC1=C(Cl)C=CC(C)(O)C1 LYOFHYLVYHTGBK-UHFFFAOYSA-N 0.000 description 1
- CGINIQPUMSCPLD-UHFFFAOYSA-N 4-chloro-2-(2-phenylethyl)phenol Chemical compound OC1=CC=C(Cl)C=C1CCC1=CC=CC=C1 CGINIQPUMSCPLD-UHFFFAOYSA-N 0.000 description 1
- ZNPSUQQXTRRSBM-UHFFFAOYSA-N 4-n-Pentylphenol Chemical compound CCCCCC1=CC=C(O)C=C1 ZNPSUQQXTRRSBM-UHFFFAOYSA-N 0.000 description 1
- HJANTALXTYZKRB-UHFFFAOYSA-N 5,5-bis(hydroxymethyl)-1,3-dimethylimidazolidine-2,4-dione Chemical compound CN1C(=O)N(C)C(CO)(CO)C1=O HJANTALXTYZKRB-UHFFFAOYSA-N 0.000 description 1
- CWSZBVAUYPTXTG-UHFFFAOYSA-N 5-[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxy-5-[4-hydroxy-3-(2-hydroxyethoxy)-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)OCCO)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 CWSZBVAUYPTXTG-UHFFFAOYSA-N 0.000 description 1
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- AJGLCXBDYCEVIE-UHFFFAOYSA-N 5-chloro-3-hydroxy-1H-pyridin-2-one Chemical compound OC1=CC(Cl)=CN=C1O AJGLCXBDYCEVIE-UHFFFAOYSA-N 0.000 description 1
- KZHMXWCJVAQSRH-UHFFFAOYSA-N 5-methyl-2-pentylphenol;3-methyl-4-propan-2-ylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C.CCCCCC1=CC=C(C)C=C1O KZHMXWCJVAQSRH-UHFFFAOYSA-N 0.000 description 1
- 229940048299 ACETYLATED LANOLIN ALCOHOLS Drugs 0.000 description 1
- 229940035676 ANALGESICS Drugs 0.000 description 1
- 240000006523 Abies balsamea Species 0.000 description 1
- 235000007173 Abies balsamea Nutrition 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N Ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 241000239290 Araneae Species 0.000 description 1
- 239000010752 BS 2869 Class D Substances 0.000 description 1
- 239000004857 Balsam Substances 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000133570 Berberidaceae Species 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N Berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 Berberine Drugs 0.000 description 1
- BVSUCQUNDWVLPY-UHFFFAOYSA-N BrC1(COCOC1)[N+](=O)[O-].C(CCCC=O)=O Chemical compound BrC1(COCOC1)[N+](=O)[O-].C(CCCC=O)=O BVSUCQUNDWVLPY-UHFFFAOYSA-N 0.000 description 1
- XVBRCOKDZVQYAY-UHFFFAOYSA-N Bronidox Chemical compound [O-][N+](=O)C1(Br)COCOC1 XVBRCOKDZVQYAY-UHFFFAOYSA-N 0.000 description 1
- LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 description 1
- LAYGXVMVSLYRRS-UHFFFAOYSA-N C(CC)OC(=O)C1=CC=C(O)C=C1.[Na].COC(=O)C1=CC=C(O)C=C1.[Na].C(C1=CC=CC=C1)OC(=O)C1=CC=C(O)C=C1.C(C(C)C)OC(=O)C1=CC=C(O)C=C1.C(C)(C)OC(=O)C1=CC=C(O)C=C1.C(C)OC(=O)C1=CC=C(O)C=C1.C(CCC)OC(=O)C1=CC=C(O)C=C1.C(CC)OC(=O)C1=CC=C(O)C=C1.COC(=O)C1=CC=C(O)C=C1 Chemical compound C(CC)OC(=O)C1=CC=C(O)C=C1.[Na].COC(=O)C1=CC=C(O)C=C1.[Na].C(C1=CC=CC=C1)OC(=O)C1=CC=C(O)C=C1.C(C(C)C)OC(=O)C1=CC=C(O)C=C1.C(C)(C)OC(=O)C1=CC=C(O)C=C1.C(C)OC(=O)C1=CC=C(O)C=C1.C(CCC)OC(=O)C1=CC=C(O)C=C1.C(CC)OC(=O)C1=CC=C(O)C=C1.COC(=O)C1=CC=C(O)C=C1 LAYGXVMVSLYRRS-UHFFFAOYSA-N 0.000 description 1
- UUDMXXMOUWRYQI-UHFFFAOYSA-N C(CCC)C1=C(O)C=CC=C1O.C(CC)C1=C(O)C=CC=C1O.C(C)C1=C(O)C=CC=C1O.CC1=C(O)C=CC=C1O.C1(O)=CC(O)=CC=C1 Chemical compound C(CCC)C1=C(O)C=CC=C1O.C(CC)C1=C(O)C=CC=C1O.C(C)C1=C(O)C=CC=C1O.CC1=C(O)C=CC=C1O.C1(O)=CC(O)=CC=C1 UUDMXXMOUWRYQI-UHFFFAOYSA-N 0.000 description 1
- JLDACQBFLQBENS-UHFFFAOYSA-N CC1=CC(O)=CC(C)=C1Cl.CC1=CC(O)=C(Cl)C(C)=C1Cl Chemical compound CC1=CC(O)=CC(C)=C1Cl.CC1=CC(O)=C(Cl)C(C)=C1Cl JLDACQBFLQBENS-UHFFFAOYSA-N 0.000 description 1
- KOVTZNHRVDWEQY-UHFFFAOYSA-N CCCC1=CC(Cl)=CC=C1O.CCCCC1=CC(Cl)=CC=C1O Chemical compound CCCC1=CC(Cl)=CC=C1O.CCCCC1=CC(Cl)=CC=C1O KOVTZNHRVDWEQY-UHFFFAOYSA-N 0.000 description 1
- 240000000218 Cannabis sativa Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 239000005745 Captan Substances 0.000 description 1
- 229940117949 Captan Drugs 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 229910052684 Cerium Inorganic materials 0.000 description 1
- 229940107161 Cholesterol Drugs 0.000 description 1
- GJWSUKYXUMVMGX-UHFFFAOYSA-N Citronellate Chemical compound OC(=O)CC(C)CCC=C(C)C GJWSUKYXUMVMGX-UHFFFAOYSA-N 0.000 description 1
- 229930008398 Citronellate Natural products 0.000 description 1
- PYLSGQWRPBRGGU-UHFFFAOYSA-N ClC1=CC(=C(C=C1)O)C.C1(=CC=CC=C1)C1=C(C=CC=C1)O.CC1(C(C(=CC=C1)C)Br)O Chemical compound ClC1=CC(=C(C=C1)O)C.C1(=CC=CC=C1)C1=C(C=CC=C1)O.CC1(C(C(=CC=C1)C)Br)O PYLSGQWRPBRGGU-UHFFFAOYSA-N 0.000 description 1
- 241000193155 Clostridium botulinum Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 229940109262 Curcumin Drugs 0.000 description 1
- 240000005497 Cyamopsis tetragonoloba Species 0.000 description 1
- 240000003624 Cymbopogon nardus Species 0.000 description 1
- 235000018791 Cymbopogon nardus Nutrition 0.000 description 1
- 210000000805 Cytoplasm Anatomy 0.000 description 1
- 229940099371 DIACETYLATED MONOGLYCERIDES Drugs 0.000 description 1
- AFFLGGQVNFXPEV-UHFFFAOYSA-N Decene Chemical compound CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 description 1
- 210000004207 Dermis Anatomy 0.000 description 1
- SOROIESOUPGGFO-UHFFFAOYSA-N Diazolidinyl urea Chemical compound OCNC(=O)N(CO)C1N(CO)C(=O)N(CO)C1=O SOROIESOUPGGFO-UHFFFAOYSA-N 0.000 description 1
- 229960003887 Dichlorophen Drugs 0.000 description 1
- MDNWOSOZYLHTCG-UHFFFAOYSA-N Dichlorophene Chemical compound OC1=CC=C(Cl)C=C1CC1=CC(Cl)=CC=C1O MDNWOSOZYLHTCG-UHFFFAOYSA-N 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M Dioctyl sodium sulfosuccinate Chemical group [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- USIUVYZYUHIAEV-UHFFFAOYSA-N Diphenyl ether Chemical class C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 1
- 230000036947 Dissociation constant Effects 0.000 description 1
- KWKXNDCHNDYVRT-UHFFFAOYSA-N Dodecylbenzene Chemical compound CCCCCCCCCCCCC1=CC=CC=C1 KWKXNDCHNDYVRT-UHFFFAOYSA-N 0.000 description 1
- 150000000914 Dysprosium Chemical class 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014970 Ephelide Diseases 0.000 description 1
- 210000002615 Epidermis Anatomy 0.000 description 1
- 229910052691 Erbium Inorganic materials 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 229940109501 Eucalyptol Drugs 0.000 description 1
- 240000000437 Eucalyptus leucoxylon Species 0.000 description 1
- 235000004694 Eucalyptus leucoxylon Nutrition 0.000 description 1
- 235000010705 Eucalyptus maculata Nutrition 0.000 description 1
- 235000009683 Eucalyptus polybractea Nutrition 0.000 description 1
- 235000009687 Eucalyptus sargentii Nutrition 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 229960002217 Eugenol Drugs 0.000 description 1
- 229910052693 Europium Inorganic materials 0.000 description 1
- CRDAMVZIKSXKFV-YFVJMOTDSA-N Farnesol Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CO CRDAMVZIKSXKFV-YFVJMOTDSA-N 0.000 description 1
- 229940043259 Farnesol Drugs 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N Ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- UIWYJDYFSGRHKR-UHFFFAOYSA-N Gadolinium Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 1
- 229910052688 Gadolinium Inorganic materials 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 210000003780 Hair Follicle Anatomy 0.000 description 1
- 235000019487 Hazelnut oil Nutrition 0.000 description 1
- 210000003128 Head Anatomy 0.000 description 1
- 229940086207 Head & Shoulders Drugs 0.000 description 1
- 229910052689 Holmium Inorganic materials 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 240000006600 Humulus lupulus Species 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 235000015912 Impatiens biflora Nutrition 0.000 description 1
- 210000001847 Jaw Anatomy 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 229940099367 LANOLIN ALCOHOLS Drugs 0.000 description 1
- 229940057905 Laureth-3 Drugs 0.000 description 1
- 235000010701 Lavanda vera Nutrition 0.000 description 1
- 240000002809 Lavandula angustifolia Species 0.000 description 1
- 235000003515 Lavandula officinalis Nutrition 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- OYHQOLUKZRVURQ-UHFFFAOYSA-N Linoleic acid Chemical compound CCCCCC=CCC=CCCCCCCCC(O)=O OYHQOLUKZRVURQ-UHFFFAOYSA-N 0.000 description 1
- 229910052765 Lutetium Inorganic materials 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-XIXRPRMCSA-N Mesotartaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-XIXRPRMCSA-N 0.000 description 1
- BEGLCMHJXHIJLR-UHFFFAOYSA-N Methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 1
- 210000004080 Milk Anatomy 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N N,N-Diethylethanamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 1
- QEFYFXOXNSNQGX-UHFFFAOYSA-N Neodymium Chemical compound [Nd] QEFYFXOXNSNQGX-UHFFFAOYSA-N 0.000 description 1
- 229910052779 Neodymium Inorganic materials 0.000 description 1
- MTFYVRROVHTUCY-UHFFFAOYSA-L OCC1(NC(=O)NCNC(=O)NC2(CO)NC(=O)NC2=O)NC(=O)NC1=O.S([O-])(O)=O.[Na+].S(=O)([O-])O.[Na+] Chemical compound OCC1(NC(=O)NCNC(=O)NC2(CO)NC(=O)NC2=O)NC(=O)NC1=O.S([O-])(O)=O.[Na+].S(=O)([O-])O.[Na+] MTFYVRROVHTUCY-UHFFFAOYSA-L 0.000 description 1
- 240000003982 Ocimum basilicum Species 0.000 description 1
- 235000010676 Ocimum basilicum Nutrition 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 241001529744 Origanum Species 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 229940067631 Phospholipids Drugs 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 240000000129 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 231100000614 Poison Toxicity 0.000 description 1
- 229920001451 Polypropylene glycol Polymers 0.000 description 1
- 229920000289 Polyquaternium Polymers 0.000 description 1
- 229910052777 Praseodymium Inorganic materials 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 229940055023 Pseudomonas aeruginosa Drugs 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010037844 Rash Diseases 0.000 description 1
- 240000003136 Rosmarinus officinalis Species 0.000 description 1
- 229940079781 SODIUM COCOYL GLUTAMATE Drugs 0.000 description 1
- 229940045944 SODIUM LAUROYL GLUTAMATE Drugs 0.000 description 1
- 229910052772 Samarium Inorganic materials 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 210000001732 Sebaceous Glands Anatomy 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 229940007046 Shigella dysenteriae Drugs 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 206010040550 Shigella infection Diseases 0.000 description 1
- 210000002832 Shoulder Anatomy 0.000 description 1
- FDNAPBUWERUEDA-UHFFFAOYSA-N Silicon tetrachloride Chemical compound Cl[Si](Cl)(Cl)Cl FDNAPBUWERUEDA-UHFFFAOYSA-N 0.000 description 1
- 229960003504 Silicones Drugs 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- 210000004927 Skin cells Anatomy 0.000 description 1
- 229940045998 Sodium Isethionate Drugs 0.000 description 1
- SRRKNRDXURUMPP-UHFFFAOYSA-N Sodium disulfide Chemical compound [Na+].[Na+].[S-][S-] SRRKNRDXURUMPP-UHFFFAOYSA-N 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M Sodium polyacrylate Chemical group [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N Squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 229940076185 Staphylococcus aureus Drugs 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229940076156 Streptococcus pyogenes Drugs 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 210000000106 Sweat Glands Anatomy 0.000 description 1
- 229940057400 TRIHYDROXYSTEARIN Drugs 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 208000009056 Telangiectasis Diseases 0.000 description 1
- 229910052775 Thulium Inorganic materials 0.000 description 1
- MGSRCZKZVOBKFT-UHFFFAOYSA-N Thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 210000001541 Thymus Gland Anatomy 0.000 description 1
- 240000008529 Triticum aestivum Species 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 240000001519 Verbena officinalis Species 0.000 description 1
- 239000004164 Wax ester Chemical class 0.000 description 1
- 229910052769 Ytterbium Inorganic materials 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000001154 acute Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000005376 alkyl siloxane group Chemical group 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 201000004384 alopecia Diseases 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000000202 analgesic Effects 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000000058 anti acne agent Substances 0.000 description 1
- 230000000111 anti-oxidant Effects 0.000 description 1
- 229940053200 antiepileptics Fatty acid derivatives Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 125000004429 atoms Chemical group 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- LLOHIFXFHGMBNO-UHFFFAOYSA-N azane;2-hydroxyethanesulfonic acid Chemical compound [NH4+].OCCS([O-])(=O)=O LLOHIFXFHGMBNO-UHFFFAOYSA-N 0.000 description 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Chemical class 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 229930015400 berberine Natural products 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 229960003168 bronopol Drugs 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 235000010957 calcium stearoyl-2-lactylate Nutrition 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- MIOPJNTWMNEORI-UHFFFAOYSA-M camphorsulfonate anion Chemical compound C1CC2(CS([O-])(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-M 0.000 description 1
- 125000001589 carboacyl group Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229920003118 cationic copolymer Polymers 0.000 description 1
- 239000012461 cellulose resin Substances 0.000 description 1
- GWXLDORMOJMVQZ-UHFFFAOYSA-N cerium Chemical compound [Ce] GWXLDORMOJMVQZ-UHFFFAOYSA-N 0.000 description 1
- 230000005591 charge neutralization Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000003889 chemical engineering Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 229940071160 cocoate Drugs 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing Effects 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 230000001066 destructive Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- SHLKYEAQGUCTIO-UHFFFAOYSA-N diazanium;4-dodecoxy-4-oxo-3-sulfobutanoate Chemical compound [NH4+].[NH4+].CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O.CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O SHLKYEAQGUCTIO-UHFFFAOYSA-N 0.000 description 1
- 229960001083 diazolidinylurea Drugs 0.000 description 1
- 229960004698 dichlorobenzyl alcohol Drugs 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 201000009910 diseases by infectious agent Diseases 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- HWUINYGRRJTXGE-UTLKBRERSA-L disodium;(2S)-2-(dodecanoylamino)pentanedioate Chemical compound [Na+].[Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O HWUINYGRRJTXGE-UTLKBRERSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecan-1-amine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 1
- HTEDBVHMHCOHGD-UHFFFAOYSA-N dodecoxy(oxo)methanesulfonic acid Chemical compound CCCCCCCCCCCCOC(=O)S(O)(=O)=O HTEDBVHMHCOHGD-UHFFFAOYSA-N 0.000 description 1
- YRIUSKIDOIARQF-UHFFFAOYSA-N dodecyl benzenesulfonate Chemical compound CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 YRIUSKIDOIARQF-UHFFFAOYSA-N 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical group [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical class CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- TVACALAUIQMRDF-UHFFFAOYSA-L dodecyl phosphate Chemical compound CCCCCCCCCCCCOP([O-])([O-])=O TVACALAUIQMRDF-UHFFFAOYSA-L 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drugs Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- UYAHIZSMUZPPFV-UHFFFAOYSA-N erbium Chemical compound [Er] UYAHIZSMUZPPFV-UHFFFAOYSA-N 0.000 description 1
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 1
- 235000001612 eucalyptus Nutrition 0.000 description 1
- 235000001617 eucalyptus Nutrition 0.000 description 1
- 235000001621 eucalyptus Nutrition 0.000 description 1
- 235000006356 eucalyptus Nutrition 0.000 description 1
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 150000002194 fatty esters Chemical class 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- KGBFVGDNQSUWBM-UHFFFAOYSA-N formaldehyde;3-iodoprop-1-enyl N-butylcarbamate Chemical compound O=C.CCCCNC(=O)OC=CCI KGBFVGDNQSUWBM-UHFFFAOYSA-N 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N fumaric acid Chemical compound OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 150000004676 glycans Polymers 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 239000003722 gum benzoin Substances 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 239000010468 hazelnut oil Substances 0.000 description 1
- 231100001045 histological change Toxicity 0.000 description 1
- 230000036732 histological change Effects 0.000 description 1
- KJZYNXUDTRRSPN-UHFFFAOYSA-N holmium Chemical compound [Ho] KJZYNXUDTRRSPN-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic Effects 0.000 description 1
- 239000003752 hydrotrope Substances 0.000 description 1
- 230000003165 hydrotropic Effects 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-M isethionate Chemical compound OCCS([O-])(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-M 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 230000000670 limiting Effects 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007650 limonene Natural products 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- OHSVLFRHMCKCQY-UHFFFAOYSA-N lutetium Chemical compound [Lu] OHSVLFRHMCKCQY-UHFFFAOYSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000008204 materials by function Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000005673 monoalkenes Chemical group 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L na2so4 Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- UFWIBTONFRDIAS-UHFFFAOYSA-N naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 1
- 229930004077 nerolidols Natural products 0.000 description 1
- 230000001264 neutralization Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N o-xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000010292 orthophenyl phenol Nutrition 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 125000001095 phosphatidyl group Chemical group 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920001888 polyacrylic acid Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- PUDIUYLPXJFUGB-UHFFFAOYSA-N praseodymium Chemical compound [Pr] PUDIUYLPXJFUGB-UHFFFAOYSA-N 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 235000005227 red mallee Nutrition 0.000 description 1
- 239000003638 reducing agent Substances 0.000 description 1
- 230000015227 regulation of liquid surface tension Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- KZUNJOHGWZRPMI-UHFFFAOYSA-N samarium Chemical compound [Sm] KZUNJOHGWZRPMI-UHFFFAOYSA-N 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N silicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000005049 silicon tetrachloride Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 230000037393 skin firmness Effects 0.000 description 1
- 230000036558 skin tension Effects 0.000 description 1
- 229940079776 sodium cocoyl isethionate Drugs 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 description 1
- 229950005425 sodium myristyl sulfate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- CITBNDNUEPMTFC-UHFFFAOYSA-M sodium;2-(hydroxymethylamino)acetate Chemical compound [Na+].OCNCC([O-])=O CITBNDNUEPMTFC-UHFFFAOYSA-M 0.000 description 1
- ZUFONQSOSYEWCN-UHFFFAOYSA-M sodium;2-(methylamino)acetate Chemical compound [Na+].CNCC([O-])=O ZUFONQSOSYEWCN-UHFFFAOYSA-M 0.000 description 1
- ZZQPOMXRWJJJGB-UHFFFAOYSA-M sodium;2-oxotridecanoate Chemical compound [Na+].CCCCCCCCCCCC(=O)C([O-])=O ZZQPOMXRWJJJGB-UHFFFAOYSA-M 0.000 description 1
- 230000000087 stabilizing Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 1
- 150000008053 sultones Chemical class 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 231100001005 telangiectasia Toxicity 0.000 description 1
- 229930007823 thymol Natural products 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N tin hydride Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 description 1
- 125000004417 unsaturated alkyl group Chemical group 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000001594 verbena Nutrition 0.000 description 1
- 235000002270 verbena Nutrition 0.000 description 1
- 235000007200 verbena Nutrition 0.000 description 1
- 235000007212 verbena Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019386 wax ester Nutrition 0.000 description 1
- 235000021307 wheat Nutrition 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- NAWDYIZEMPQZHO-UHFFFAOYSA-N ytterbium Chemical compound [Yb] NAWDYIZEMPQZHO-UHFFFAOYSA-N 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Abstract
La presente invención se refiere a una composición limpiadora antimicrobiana enjuagable que comprende de alrededor de 0.1%a alrededor de 5%de un activo antimicrobiano, de alrededor de 8%a alrededor de 18%de un agente tensioactivo aniónico, de alrededor de 2%a alrededor de 12%de un agente donador de protón;de alrededor de 1%a alrededor de 30%de un agentehumectante lipofílico de la piel;de alrededor de 0.1%a alrededor de 4%de un estabilizador, y de alrededor de 35%a alrededor de 88.8%de agua;al menos alrededor de 67%del agente tensioactivo aniónico comprende una mezcla de agente tensioactivo de clase A y clase C;la relación de peso del agente tensioactivo de clase A al agente tensioactivo de clase C varía de alrededor de 5:1 a alrededor de 1:2;la composición se ajusta a un pH de alrededor de 3.5 a alrededor de 4.5.
Description
LIQUID ANTIMICROBIAL CLEANING COMPOSITIONS
TECHNICAL FIELD
The present invention relates to mild, rinseable personal cleansing compositions that provide improved antimicrobial effectiveness. Specifically, the personal cleansing compositions of the invention provide residual effectiveness not previously seen against transient Gram-negative bacteria, improved levels of residual effectiveness against Gram-positive bacteria and improved immediate reduction of germs on the skin with use.
BACKGROUND OF THE INVENTION
Human health is impacted by many microbial entities.
Inoculation by viruses and bacteria causes a wide variety of diseases and conditions. Media attention to cases of food poisoning, strep infections, and the like is increasing the public's awareness of microbial issues. It is well known that washing hard surfaces, foods (for example fruits or vegetables) and skin, especially hands, with antimicrobial or non-medicated soap, can remove many viruses and bacteria from washed surfaces. The removal of viruses and bacteria is due to the surfactant activity of the soap and the mechanical action of the washing process. Therefore, it is known and recommended that people wash frequently to reduce the spread of viruses and bacteria. The bacteria found on the skin can be divided into two groups: resident and transient bacteria. The resident bacteria are Gram-positive bacteria that are established as permanent microcolonies on the surface and outer layers of the skin and play an important role, helping to prevent the colonization of other bacteria and more harmful fungi. Transient bacteria are bacteria that are not part of the normal resident flora of the skin, but can be deposited when the contaminated material transported by air lands on the skin or when the contaminated material comes into physical contact with it. Transient bacteria are typically divided into two subclasses: Gram positive and Gram negative. Gram-positive bacteria include pathogens such as Staphylococcus aureus, Streptococcus pyogenes and Clostridium botulinum. Gram-negative bacteria include pathogens such as Salmonella, Escherochia coli, Klebsiella, Hoemophilus, Pseudomonas aeruginosa, Proteus and Shigella dysenteriae. Gram-negative bacteria are generally distinguished from Gram-positive bacteria by an additional protective cell membrane that generally results in Gram-negative bacteria being less susceptible to topical antibacterial actives.
Antimicrobial cleaning products have been marketed in a variety of forms for some time. The forms include deodorant soaps, hard surface cleaners and surgical disinfectants. These traditional rinsing antimicrobial products have been formulated to provide bacteria removal during washing. Antimicrobial soaps have also been shown to provide residual effectiveness against Gram-positive bacteria. Residual effectiveness refers to the fact that the growth of bacteria on a surface is controlled by a pepodo after the washing / rinsing procedure. Liquid antimicrobial cleaners are described in U.S. Patent No. 4,847,072, Bissett et al; issued on July 1, 1989, 4,939,284, Degenhardt, issued July 3, 1990 and 4,829,698, Degenhardt, issued April 11, 1989, which are incorporated herein by reference. The previously marketed formulations of Head & Dandruff Shampoo Shoulders®, marketed in 1994, comprise anionic surfactants, an antibacterial active and citric acid as a pH adjuster. The Head & Shoulders®, controls the fungus Pityrosorum ovale, which causes dandruff. The PCT application WO 92/18100, Keegan et al.; published October 29, 1992 ("Keegan") and the PCT application WO 95/32705, Fijiwara et al; published on December 7, 1995 ("Fujiwara") show liquid skin cleansers comprising mild surfactants, antibacterial agents and acidic compounds to regulate pH, which provides enhanced Germ hostility. However, the use of the low levels of the acidic compounds herein results in compositions that do not provide the disassociated acid required to provide the residual effectiveness against the Gram negative bacteria. The above situation is composed in Keegan and Fujiwara by the preference of mild surfactants, including nonionic surfactants. Some of these antimicrobial products, especially hard surface cleaners and surgical disinfectants, use high levels of alcohol and / or harsh surfactants that have been shown to dry and irritate skin tissues. Ideal personal cleansers should gently cleanse the skin, causing little or no irritation, and not leaving the skin extremely dry after frequent use and preferably should provide a moisturizing benefit to the skin. U.S. Patent No. 3,141, 8121, issued to Compeau, July 21, 1964 and Irgasan DP 300 (Triclosan®) technical literature from Ciba-Giegy, Inc., "Basic Formulation for Hand Disinfection 89/42/01" disclose antibacterial skin cleansing compositions that could provide residual effectiveness against Gram-negative bacteria using certain anionic surfactants, antimicrobial actives and acids. However, the selection, in the present, of highly active surfactants results in personal cleansing compositions that dry and roughen the skin.
Given the high severe health impacts of Gram negative bacteria such as Salmonella, Escherichia coli and Shigella, it would be highly desirable to formulate antimicrobial cleansing compositions that provide improved residual effectiveness against said Gram negative bacteria and which are gentle to the skin. The existing products have been unable to achieve the residual effectiveness and smoothness of the negative Gram. Applicants have discovered that rinsing antimicrobial cleaning compositions that provide such softness and such residual effectiveness against Gram-negative bacteria can be formulated using known antibacterial actives in combination with specific organic and / or inorganic acids as proton donor agents, and specific anionic surfactants , all of which are deposited on the skin. The deposited proton donor agent and the anionic surfactant enhance the selected asset, to provide a new level of hostility to the bacteria that contacts the skin.
BRIEF DESCRIPTION OF THE INVENTION
The present invention relates to a rinsable antimicrobial cleaning composition comprising from about 0.1% to about 5.% of an antibacterial active; from about 8% to about 18% anionic surfactant; from about 2% to about 12% of a proton donor agent; from about 1% to about 20% of a lipophilic skin moisturizing agent; from about 0.1% to about 4% of a stabilizer and from about 38% to about 88% water. At least about 67% of an anionic surfactant comprises a mixture of Class A and Class C surfactants, wherein the weight ratio of the class A surfactants to class C surfactants varies from about 5: 1. to around 1: 2. The compositions of the present invention have a pH of around 3.5 to about 4: 5. The present invention also relates to cleaning methods and to reducing the distribution of transient Gram-negative bacteria using the rinse-off antimicrobial cleaning compositions described herein.
DETAILED DESCRIPTION OF THE INVENTION
The rinsing antimicrobial compositions of the present invention are very effective in cleaning surfaces, especially the skin, providing a residual antimicrobial effectiveness against transient Gram-negative bacteria and are gentle on the skin. The term "rinseable", as used herein, refers to the compositions of the present invention being used in a context where the composition is rinsed or finally washed from the treated surface (e.g., skin or hard surfaces) after or during the application of the product.
The term "antimicrobial cleansing composition", as used herein, refers to a composition suitable for application to a surface for the purpose of removing dirt, oil or the like which additionally controls the growth and colonization of transient bacteria. Gram negative Preferred embodiments of the present invention are cleaning compositions suitable for use on human skin. The compositions of the present invention may also be useful for the treatment of acne. As used in the present "acne treatment" it refers to the prevention, delay and / or cancellation of the acne formation process in mammalian skin. The compositions of the invention may also potentially be useful to provide essentially immediate visual (ie, acute) improvement to the appearance of the skin after application of the composition to the skin. More particularly, the compositions of the present invention are useful for regulating skin diseases, including the regulation of visible and / or tactile discontinuities of the skin, including but not limited to visible and / or tactile discontinuities in the texture of the skin and / or color, more specifically discontinuities associated with skin aging. Such discontinuities can be induced or caused by internal and / or external factors. Extrinsic factors include ultraviolet radiation (e.g., from sun exposure), environmental pollution, wind, heat, low humidity, harsh surfactants, abrasives, and the like. Intrinsic factors include chronological aging and other biochemical changes within the skin. The regulation of skin diseases includes regulating the skin disease prophylactically and / or therapeutically. As used herein, prophylactically regulating skin disease includes removing layers, minimizing and / or avoiding visible and / or tactile discontinuities in the skin. As used herein, therapeutically regulating skin disease includes improving, for example, decreasing, minimizing and / or eliminating such discontinuities. The regulation of skin disease involves improving the appearance and / or sensation of the skin, for example, causing a smoother or more uniform appearance and / or feeling. As used herein, regular skin disease includes regular signs of aging. "Regulating Signs of Skin Aging" includes prophylactically and / or therapeutically regulating one or more of such signals (similarly, regulating a given signal of aging of the skin, for example, lines, wrinkles or pores, which includes prophylactically regulating and / or therapeutically regulate said signal). "Signs of skin aging" include, but are not limited to, all visible and tactilely perceptible manifestations as well as any other macro or microefectos due to aging of the skin. These signals may result from procedures that include, but are not limited to, the development of texture discontinuities such as wrinkles, including fine surface wrinkles and coarse deep wrinkles, skin lines, baldness, eruptions, large pores (eg, associated with afnexal structures). as learned of sweat gland, sebaceous gland, or hair follicles), scaly, lamellate consistency and / or other forms of disuniformity or roughness of skin, loss of skin elasticity (loss and / or inactivation of functional skin elastin), softening (including puffiness in the eye area and jaw), loss of skin firmness, loss of skin tension, loss of skin recovery from deformation, discoloration (including circles under the eye), blotching, sallowness, regions hyperpigmented skin such as age spots and freckles, keratosis, abnormal differentiation, hyperkeratinization, elastosis, decomposition collagen and other histological changes in the stratum corneum, dermis, epidermis, the skin tilting system (e.g., telangiectasia or spider vessels), and underlying tissues, especially those close to the skin. All percentages and ratios used herein, unless otherwise indicated, are by weight and all measurements are made at 25 ° C, unless otherwise designated. The invention herein may consist, consist of or consist essentially of the essential as well as optional ingredients and components described therein.
1. - Ingredients The rinsing antimicrobial cleansing compositions of the present invention comprise Triclosan®, an anionic surfactant, a proton donor agent, a lipophilic skin wetting agent, a stabilizer and water. Each of these ingredients is described in detail below.
A. Antimicrobial Active The rinsing antimicrobial cleaning compositions of the present invention comprise from about 0.1% to about 5%, preferably from about 0.1% to about 2%, and more preferably from 0.1% to about 1% of an active antimicrobial. Non-cationic actives are required in order to avoid interaction with the anionic surfactants of the invention. Examples of non-cationic antimicrobial agents that are useful in the present invention are given below. Pyrithiones, especially the zinc complex (ZPT) Octopirox® Dimethyldimethylolhydantoin (Glidant®) Methylchloroisothiazolinone / methylisothiazolinone (Kathon CG®) Sodium sulphite Sodium bisulphite Imidazolidinylurea (Germall 115®) Diazolidinylurea (Germall ll®) Benzyl alcohol 2-Bromo-2 -nitropropane-1,3-dioI (Bronopol®) Formalin (formaldehyde) iodopropenyl Butylcarbamate (Polifase P100®) Chloroacetamide Methanamine Metildibromonitrile-GIutaronitrile (1,2-Dibromo-2,4-dicyanobutane or Tektamer®) Glutaraldehyde 5-bromo- 5-nitro-1, 3-dioxane (Bronidox®) Phenethyl alcohol o-Phenylphenol / sodium o-phenylphenol Sodium hydroxymethylglycan (Suttocide A®) Bicyclic polymethoxyoxazolidine (Nuosept C®) Dimetoxan Timersal Dichlorobenzyl alcohol Captan Chlorphenenesin Dichlorophene Chlorbutanol Glycerylurea Halogenated diphenyl ethers Ether 2,4,4, -trichloro-2, -hydroxy-diphenium (Triclosan® or TCS) 2,2'-Dihydroxy-5,5, -diobromo-d-phenyl ester phenolic compounds phenol 2-methylphenol 3-methylphenol 4-methylphenol 4-ethylphenol 2,4-dimethylphenol 2,5-dimethylphenol 3,4-dimethylphenol 2,6-dimethylphenol 10 4-n-propylphenol 4-n-butylphenol 4-n- Amylphenol 4-tert-Amylphenol 4-n-hexylphenol 15 4-n-Heptyphenol Mono- and poly-alkyl aromatic allophenols p-chlorophenol Methyl p-chlorophenol Ethyl p-chlorophenol 20 n-propyl p-chlorophenol n-butyl p-chlorophenol n -amil p-chlorophenol sec-amyl p-chlorophenol n-hexyl p-chlorophenol Cyclohexyl p-chlorophenol n-heptyl p-chlorophenol n-octyl p-chlorophenol o-chlorophenol Methyl o-chlorophenol Ethyl o-chlorophenol n-propyl o-chlorophenol n-butyl o-chlorophenol 10 n-amyl o-chlorophenol tert-amyl o-chlorophenol n-hexyl o-chlorophenol n-heptyl o-chlorophenol o-benzyl p-chlorophenolo-benzyl-m-methyl p-chlorophenol
o-benzyl-m, m-dimethyl p-chlorophenol or phenylethyl p-chlorophenol or phenylethyl-m-methyl p-chlorophenol 3-methyl p-chlorophenol 3,5-dimethyl p-chlorophenol 6-ethyl- 3-methyl p-chlorophenol 6-n-propyl-3-methyl p-chlorophenol 6-iso-propyl-3-methyl p-chlorophenol 2-ethyl-3,5-dimethyl p-chlorophenol 6-sec-butyl-3- methyl p-chlorophenol 2-iso-propyl-3,5-dimethyl p-chlorophenol 6-diethylmethyl-3-metii p-chlorophenol 6-iso-propyl-2-ethyl-3-methyl p-chlorophenol 2-sec-amyl- 3,5-dimethyl p-chlorophenol 2-diethylmethyl-3,5-dimethyl p-chlorophenol 6-sec-octyl-3-methyl p-chlorophenol p-chloro-m-cresol p-bromophenol 10 Methyl p-bromophenol Ethyl p- bromophenol n-propyl p-bromophenol n-butyl p-bromophenol n-amyl p-bromophenol 15 sec-amyl-p-bromophenol n-hexyl p-bromophenol Cyclohexyl p-bromophenol o-bromophenol ter-amyl o-bromophenol 20 n-hexyl o-bromophenol n-propyl-m, m-dimethyl o-bromophenol 2-phenylphenol 4-chloro-2-methylphenol 4-cynor-3-methylphenol 4-chloro-3,5-dimethylphenol 2,4-dichloro-3,5 -dimethylphenol 3,4,5,6-terabromo-2-methylphenol 5-methyl-2-pentylphenol 4-isopropyl-3-methylphenol Para-chloro-meta-xylene (PCMX)
Chlorothymol Phenoxyethanol Fenoxisopropanol 5-chloro-2-hydroxydiphenylmethane Resorcinol and its Derivatives Resorcinol methylresorcinol ethylresorcinol n-propyl resorcinol n-butylresorcinol n-amilresorcinol n-hexylresorcinol n-heptilresorcinol n-octilresorcinol n-nonilresorcinol fenilresorcinol Bencilresorcinol Feniletilresorcinol Fenilpropilresorcinol p-clorobencüresorcinol 5-chloro-2 , 4-dihydroxydiphenylmethane 4'-chloro-2,4-dihydroxydiphenyl-methane 5-bromo-2,4-dihydroxydiphenylmethane-4, -bromo-2,4-dihydroxydiphenyl-methane Bisphenol-2,2'-methylene-bis (4-chlorophenol) 2,2'-methylene compounds bis (3,4,6-trichlorophenol) 2,2'-methylene bis (4-chloro-6-bromophenol) bis (2-hydroxy-3,5-dichlorophenyl) sulphide)
Bis (2-hydroxy-5-chlorobenzyl) sulphide Benzoic esters (Parabens) Methylparaben Propylparaben Butylparaben Ethylparaben Isopropylparaben Isobutylparaben Benzylparaben Methylparaben sodium Propylparaben sodium CarbanilidesHalogenates 3,4,4'-trichlorcarbanilides (Triclocarban® or TCC) 3-trifluoromethyl-4 , 4'-dichlorocarban 3,3 ', 4-trichlorocarbanilide Another class of antibacterial agents, which are useful in the present invention are the so-called "natural" anticaber assets, referred to as natural essential oils. These assets derive their names from their natural occurrence in plants. Typical natural essential oil antibacterial actives include anise, lemon, orange, rosemary, caulteria, thymus, lavender, clavero, hops, tea tree, citronella, wheat, barley, lemon, cedar leaf, cedar wood, cinnamon oils , grass pulguera, geranium, sandalwood, violet, blueberry, eucalyptus, verbena, pepper, benzoin gum, basil, fennel, fir, balsam, menthol, ocmea origanum, Hydastis carradensis, Berberidaceae daceae, Ratanhiae and Curcuma longa. Also included in this class of natural essential oils are the key chemical components of plant oils that have been found to provide the antimicrobial benefit. These chemicals include, but are not limited to, anethole, catecholane, camphene, carbacola, eugenol, eucalyptol, ferulic acid, farnesol, inoquitiol, propolene, limonene, menthol, methyl salicylate, thymol, terpiniol, verbenone, berberine, ratanhiae extract , cariophelene oxide, citronellic acid, curcumin, nerolidol and genariol.
Additional active agents are antibacterial metal salts. This class generally includes salts of metals in groups 3b-7b, 8 and 3a-5a. Specifically, they are the aluminum, zirconium, zinc, silver, gold, copper, lead, tin, mercury, bismuth, seleneo, strontium, ixtium, cerium, praseodymium, neodymium, prometheus, samarium, europium, gadolinium, terbiumium, dysprosium salts. , holmium, erbium, thulium, ytterbium, lutetium and mixtures thereof. Preferred antimicrobial agents for use herein are the broad spectrum active agents selected from the group consisting of Triclosan®, Triclocarban®, Octopirox®, PCMX, ZPT, natural essential oils and their key ingredients, and mixtures thereof. The most preferred antimicrobial active for use in the present invention is Triclosan®.
B. Anionic Surfactant The rinsing antimicrobial cleaning compositions of the present invention comprise from about 8% to about 18%, preferably from about 8% to about 16% and more preferably from 8% to about 12%, by weight of the personal cleansing composition, of an anionic surfactant. Without being limited by theory, it is believed that the anionic surfactant breaks the lipid in the cell membrane of the bacteria. The particular acid used herein reduces the negative charges on the cell wall of the bacteria, traverses through the cell membrane, weakened by the surfactant, and acidifies the cytoplasm of the bacteria. The antimicrobial active can then pass more easily through the weakened cell wall, and more efficiently poison the bacteria. Non-limiting examples of anionic foaming surfactants useful in the compositions of the present invention are described in McCutcheon's, Deterqents and Emulsifiers, North American edition (1990), published by The Manufacturing Confectioner Publishing Co .; McCutcheon's, Functional Materials, North American edition (1992); and in U.S. Patent No. 3,929,678 to Laughlin et al., issued December 30, 1975, all of which are incorporated by reference. A wide variety of anionic surfactants are potentially useful herein. Non-limiting examples of anionic foaming surfactants include those selected from the group consisting of alkyl and alkyl ether sulfatessulphated monoglycerides, sulphonated olefins, alkylarylsulfonates, primary and secondary alkanesulfonates, alkyl sulfosucinates, acryl taurates and acyl isethionates, alkyl glyceryl ether sulphonates, sulfonated methyl esters, sulfonated fatty acids, alkyl phosphates, acyl glutamates, acyl sarcosinates, sulfoacetates alkyl, acylated peptides, ether carboxylates, acyl lactylates, fluoroanionic surfactants, and mixtures thereof. Mixtures of anionic surfactants can be used effectively in the present invention.
Anionic surfactants for use in cleaning compositions include alkyl and alkyl ether sulfates. These materials have the respective formulas R1O-SO3M and R1 (CH2HO) x- O-SO3M, wherein R1 is a saturated or unsaturated, branched or unbranched alkyl group of 8 to 24 carbon atoms, x is 1 to 10, and M is a water-soluble cation such as ammonium, sodium, potassium, magnesium, triethanolamine, diethanolamine and monoethanolamine. Alkyl sulphates are preferably made by sulfation of monohydric alcohols (having from 8 to 24 carbon atoms) using sulfur trioxide or other known sulfation technique. Alkyl ether sulfates are typically made as condensation products of ethylene oxide and monohydric alcohols (having from 8 to 24 carbon atoms) and then sulfated. These alcohols can be derived from fats, for example, coconut or wood oils, or they can be synthetic. Specific examples of alkyl sulfates that can be used in the cleaning compositions are sodium, ammonium, potassium, magnesium, or TEA salts of lauryl or myristyl sulfate. Examples of alkyl ether sulfates that may be used include ammonium sulfate, sodium sulfate, magnesium, or laureth-3 TEA. Another suitable class of anionic surfactants are the sulphated monoglycerides of the form R 1 CO-O-CH 2 -C (OH) H-CH 2 -O-SO 3 M, wherein R 1 is a saturated or unsaturated, branched or unbranched alkyl group of 8 to 24 carbon atoms, and M is a water-soluble cation such as ammonium, sodium, potassium, magnesium, triethanolamine, diethanolamine and monoethanolamine. This is typically done by the reaction of glycerin with fatty acids (having from 8 to 24 carbon atoms) to form a monoglyceride and the subsequent sulfation of this monoglyceride with sulfur trioxide. An example of a sulfated monoglyceride is sodium cocomonoglyceride sulfate. Other suitable anionic surfactants include olefin sulfonates of the form R1SO3M, wherein R1 is a mono-olefin having from 12 to 24 carbon atoms, and M is a water-soluble cation such as ammonium, sodium, potassium, magnesium, triethanolamine , diethanolamine and monoethanolamine. These compounds can be produced by alpha olefin sulfonation by means of non-complex sulfur trioxide, followed by neutralization of the acid reaction mixture under conditions such that any sultone that has been formed in the reaction is hydrolysed to give the corresponding hydroxyalkanesulfonate. An example of a sulfonated olefin is C1-C6 alpha-olefin sulfonate. Other suitable anionic surfactants are linear sulfoalkylbenzene sulphonates of the form R 1 -C 6 H 4 -S 3? M, wherein R 1 is a saturated or unsaturated, branched or unbranched alkyl group of 8 to 24 carbon atoms, and M is a soluble cation in water such as ammonium, sodium, potassium, magnesium, triethanolamine, diethanolamine and monoethanolamine. These are formed by the sulfonation of linear alkylbenzene with sulfur trioxide. An example of this anionic surfactant is sodium dodecylbenzenesulfonate.
Still other suitable anionic surfactants for this cleaning composition include the primary or secondary alkan sulfonates of the form R 1 S 3 M, wherein R 1 is a saturated or unsaturated, branched or unbranched alkyl chain of 8 to 24 carbon atoms, and M is a water-soluble cation such as ammonium, sodium, potassium, magnesium, triethanolamine, diethanolamine and monoethanolamine. These are commonly formed by the sulfonation of paraffins using sulfur dioxide in the presence of chlorine and ultraviolet light or another known sulfonating method. Sulfonation can occur in the secondary or primary positions of the alkyl chain. An example of an alkan sulfonate useful herein is the alkali metal or ammonium paraffinsulfonate of C? 3-C? . Other suitable surfactants are alkyl sulfosuccinates, which include disodium N-octadecylsulfosucinamate.; diammonium lauryl sulfosuccinate; N- (1,2-dicarboxyethyl) -N-octadecylsulfosucinate tetrasodium; diamyl ester of sodium sulfosucinic acid; dihexyl ester of sodium sulfosuccinic acid; and dioctyl esters of sodium sulfosuccinic acid. Also useful are taurates that are based on taurine, which is also known as 2-aminoethane-sulphonic acid. Examples of taurates include N-alkyl taurines such as that prepared by reacting dodecylamine with sodium isethionate according to the teaching of U.S. Patent 2,658,072, which is incorporated herein by reference in its entirety. Other examples based on taurine include the acyl taurines formed by the reaction of N-methyltaurine with fatty acids (having from 8 to 24 carbon atoms). Another class of anionic surfactants suitable for use in the cleaning composition are the acyl isethionates. Acyl isethionates typically have the formula R 1 CO-O-CH 2 CH 2 SO 3 M, wherein R 1 is a saturated or unsaturated, branched or unbranched alkyl group having from 10 to 30 carbon atoms, and M is a cation. These are typically formed by the reaction of fatty acids (having from 8 to 30 carbon atoms) with an alkali metal isethionate. Non-limiting examples of these acyl isethionates include cocoyl ammonium isethionate, sodium cocoyl isethionate, sodium laureth isethionate, and mixtures thereof. Still other suitable anionic surfactants are the alkylglyceryl ether sulphonates of the form R1-CH (SO4) -COOH, wherein R1 is a saturated or unsaturated, branched or unbranched alkyl group of 8 to 24 carbon atoms, and M is a water-soluble cation such as ammonium, sodium, potassium, magnesium, triethanolamine, diethanolamine and monoethanolamine. These can be formed by the reaction of epichlorohydrin and sodium disulfide with fatty alcohols (having from 8 to 24 carbon atoms) or other known methods. An example is sodium co-glyceryl sulphonate ether. Other suitable anionic surfactants include the sulfonated fatty acids of the form R1-CH (SO) -COOH and the sulfonated methyl esters of the form R1-CH (SO) -CO-O-CH3, wherein R1 is an alkyl group saturated or unsaturated, branched or unbranched, from 8 to 24 carbon atoms. These may be formed by the sulfonation of fatty acids or methylalkyl esters (having from 8 to 24 carbon atoms) with sulfur trioxide or by another known sulfonating technique. Examples include aliphatic acid coconut fatty acid and laurimethyl ester. Other anionic materials include phosphates such as monoalkyl, dialkyl, and trialkyl phosphate salts formed by the reaction of phosphorus pentoxide with branched or unbranched monohydric alcohols having from 8 to 24 carbon atoms. These could also be formed by other known phosphating methods. An example of this class of surfactants is sodium monodilauryl phosphate. Other anionic materials include acyl glutamates corresponding to the formula R1CO-N (COOH) -CH2CH2-CO2M, wherein R1 is a saturated or unsaturated, branched or unbranched alkyl or alkenyl group, of 8 to 24 carbon atoms, M is a cation soluble in water. Non-limiting examples of which include sodium lauroylglutamate and sodium cocoylglutamate. Other anionic materials include alkanoyl sarcosinates corresponding to the formula R1CON (CH3) -CH2CH2-C2M wherein R1 is a saturated or unsaturated, branched or unbranched alkyl or alkenyl group, of 10 to 20 carbon atoms, and M is a cation soluble in water. Non-limiting examples of which include sodium lauroyl sarcosinate, sodium cocoyl sarcosinate and lauroyl sarcosinate ammonium. Other anionic materials include the alkyl carboxylate ethers corresponding to the formula R1- (OCH2CH2)? -OCH2-C? 2M, wherein R1 is a saturated or unsaturated alkyl or alkenyl group, branched or unbranched of 8 to 24 carbon atoms, x is 1 to 10, and M is a water soluble cation. Non-limiting examples of which include sodium laurethcarboxylate. Other anionic materials include acyl lactylates corresponding to the formula R1CO- [O-CH (CH3) -CO] x -CO2M, wherein R is a saturated or unsaturated, branched or unbranched alkyl or alkenyl group of 8 to 24 atoms of carbon, x is 3, and M is a water-soluble cation. Non-limiting examples of which include sodium lauroylcarboxylate, sodium cocoylcarboxylate, and ammonium lauroylcaboxylate. The fluoroanionic surfactants can also be used. Any countercation, M, can be used on the anionic surfactant. Preferably the counter cation is selected from the group consisting of sodium, potassium, ammonium, monoethanolamine, diethanolamine, and triethanolamine. More preferably the countercation is ammonium. Although any of said surfactants can be employed in the liquid antimicrobial cleansing compositions herein, at least about 67%, preferably at least about 80% and more preferably at least about 90% of the anionic surfactant present in the Liquid antimicrobial compositions herein comprise a mixture of class A and class C surfactants as defined below. The weight ratio of the class A surfactants to class C surfactants ranges from about 5: 1 to about 1: 2, preferably from about 4: 1 to about 1: 1. The surfactants mainly used in the compositions of the present invention can be grouped into four classes based on their softness and antimicrobial efficacy. The four classes of anionic surfactants are defined below. Class A - The first class of anionic surfactants are those that are considered mild, but which improve antimicrobial efficacy to a minimum. These include the group consisting of alkyl ether sulfates; acyl monoglyceryl sulphates; alkyl glyceryl ether sulfates; acyl isethionates; acyltaurates; alkyl sulfosuccinates; alkylsulfoacetates; sulfonated olefins; alkyl sulfates having a predominant chain length of C8, C10, C16 or C18; and mixtures thereof. Class B - The second class of surfactants are those that are considered mild, but which improve antimicrobial efficacy. These include the group consisting of primary and secondary alcansulfonates, alkyl sulfates having a predominant chain length of C14, and mixtures thereof.
Class C - The third class of cationic surfactants are those that are considered rough but generally improve antimicrobial efficacy. These include the group consisting of alkylarylsulfonates, alkylsulfocarboxylates, sulfonated fatty acids, alkyl phosphates, alkylsulfates having to have a predominant chain length of C12, and mixtures thereof. Specific examples of harsh surfactants are lauryl phosphate, laurylbenzenesulfonate, monolaryl phosphate and lauryl sulfocarboxylate. Class D - The fourth class of surfactants consists of surfactants having a pka greater than 4.0. It has been found that such surfactants are generally mild and very effective. These include the group consisting of acyl sarcosinates, acylglutamates, alkyl ether carboxylates and mixtures thereof. It has been discovered that the nonionic surfactants of the group consisting of nonionic surfactants, cationic surfactants, amphoteric surfactants and mixtures thereof, inhibit the residual effectiveness benefits when used with anionic surfactants at high levels. The foregoing is more evident in the case of cationic and amphoteric agents, where it is believed that said amphoteric agents interfere with the ability of the anionic surfactant to interrupt the lipid in the cell membrane (charge-charge interaction). The ratio of the amount of said non-anionic surfactants to the amount of the anionic surfactant should be less than 1: 1, preferably less than 1: 2, and more preferably less than 1: 4 in the compositions herein. The rinsing antimicrobial cleaning compositions of the present invention preferably do not comprise hydrotropic sulfonates, particularly terpenoid salts, or mono- or binuclear aromatic compounds such as camphor sulfonate, toluene, xylene, eumeno and naphthene.
C. Proton donor agent The rinse antimicrobial cleaning compositions of the present invention comprise from about 2% to about 12%, more preferably from about 2% to about 10%, more preferably from about 2% to about 9%, and more preferably from about 4% to about 9% based on the weight of the personal cleansing composition, of a proton donor agent. "Proton donor agent" refers to any acid compound or mixture thereof, which results in an acid dissociated on the skin after use. The proton donor agents may be organic acids, including polymeric acids, mineral acids or mixtures thereof.
Organic Acids The proton donor agents that are organic acids remain at least partially dissociated in the pure composition and remain when the compositions are diluted during washing and rinsing. The proton donor agent of organic acid must have at least a pka value of less than 5.5. Such organic proton donor agents can be added directly to the composition in the acid form or can be formed by the addition of the conjugate base of the desired acid and a sufficient amount of a separate acid sufficiently strong to form the acid disassociated from the base .
organic acid biological activity index Preferred organic proton donor agents are selected based on their biological activity. This activity is represented by an index of biological activity, Z, which is defined as: Z = 1 + 0.25pKa1 + 0.42logP The index of biological activity combines the characteristics of dissociation and hydrophobicity of the acid. It is important that the non-dissociated proton donating agent of the composition is deposited on the skin to reduce the negative charge on the cell wall. The acid dissociation constant, pKai, is indicative of the chemical's proton donor capacity in relation to the pH of the medium to which it is incorporated. Although the non-dissociated acid is the most preferred in the composition, acids with higher pKas are generally more preferred for a given pH product. The octanol-water partition coefficient, P, represents the tendency of materials in solution to prefer oils or water. Essentially it is a measure of the hydrophobic nature of a material in solution: the higher the division coefficient, the more soluble in oil, and less soluble in water. Although it is desired that the acids dissolved in the compositions arise from aqueous cleaner on application, are deposited on the oil-based skin and remain during rinsing, organic acids with higher octanol-water cleavage coefficients are most preferred. Preferred organic proton donor agents of the rinsing antimicrobial cleansing compositions of the present invention have a biological activity index greater than about 0.75, preferably greater than about 1.0 more preferably greater than about 1.5 and more preferably greater than 2.0.
Mineral acids The proton donor agents that are mineral acids will not remain dissociated in the pure composition. Despite this, it has been discovered that mineral acids can be effective proton donors for use herein. Without being limited by theory, it is believed that the strong mineral acid acidifies the carboxylic and phosphatidyl groups in proteins of the skin cells, thereby providing acid not dissociated in situ. These proton donor agents can only be added directly to the composition in the acid form.
pH It is critical to achieve the benefits of the invention that the acid not disassociated from the proton donor agent (deposited or formed in situ) remains on the skin in the protonated form. Therefore, the pH of the non-rinsing antimicrobial compositions of the present invention must be adjusted to a sufficiently low level in order to form or deposit substantially non-destructive acid on the skin. The pH of the compositions should be adjusted and preferably regulated in the range from about 3.0 to about 6.0, preferably from about 3.5 to about 5.0 and more preferably from about 3.5 to about 4.5. A non-exclusive list of examples of organic acids that can be used as the proton donor agent are adipic acid, tartaric acid, citric acid, maleic acid, malic acid, succinic acid, glycolic acid, glutaric acid, benzoic acid, malonic acid , salicylic acid, gluconic acid, polyacrylic acid, its salts, and mixtures thereof. Especially preferred organic proton donor agents are the group consisting of malic acid, malonic acid, citric acid, succinic acid, and lactic acid, a non-exclusive list of examples of mineral acid to be used herein are hydrochloric, phosphoric, sulfuric and mixtures thereof.
D. Lipophilic Skin Moisturizing Agent The liquid rinseable, antimicrobial personal cleansing compositions herein comprise from about 1% to about 30%, preferably from about 3% to about 25%, more preferably about 5%. % to about 25% of a lipophilic skin moisturizing agent. It has been found that compositions containing a lipophilic skin moisturizing agent have improved their antibacterial efficacy compared to compositions that do not contain a lipophilic skin moisturizing agent. In addition, the lipophilic moisturizing agent of the skin provides a wetting benefit to the user of the personal cleansing product when the lipophilic moisturizing agent of the skin is deposited on the wearer's skin. Two types of rheological parameters are used to define the lipophilic moisturizing agent of the skin used herein. The viscosity of the lipophilic wetting agent of the skin is represented by the consistency (k) and shear rate (n). The lipophilic skin moisturizing agents for use herein typically have a consistency (k) ranging from about 5 to about 5000 poises, preferably from about 10 to about 3000 poises, more preferably about 50. to about 2000 poises, as measured by the consistency method (k) described later in the analytical methods section. The lipophilic skin moisturizing agents suitable for use herein also have a shear rate (n) ranging from about 0.1 to about 0.9, preferably from about 0.1 to about 0.5, more preferably around from 0.2 to around 0.5, as measured by the shear index method described later in the analytical methods section. Although not limited by theory, it is believed that lipophilic skin moisturizing agents have rheological properties different from those defined herein that are emulsified very easily and therefore do not deposit, or are too "rigid" to adhere or deposit to the skin and provide a moisturizing benefit. In addition, the rheological properties of the lipophilic wetting agent of the skin are also important for the user's perception. Some lipophilic moisturizing agents of the skin, when deposited on the skin, are considered very sticky and are not preferred by the user. In some cases, the lipophilic skin moisturizing agent may desirably be defined in terms of its solubility parameter, as defined by Vaughan in Cosmetics and Toiletries, Vol. 103, p. 47-69, October 1988. A lipophilic skin moisturizing agent having a Vaughan solubility parameter (VSP) of from 5 to 10, preferably from 5.5. to 9 is suitable for use in the present antimicrobial compositions. A wide variety of lipid type materials and mixtures of materials are suitable for use in the rinsing antimicrobial cleaning compositions of the present invention. Preferably, the lipophilic skin conditioning agent is selected from the group consisting of hydrocarbon oils and waxes, silicones, fatty acid derivatives, cholesterol, cholesterol derivatives, di-and tri-glycerides, vegetable oils, vegetable oil derivatives, liquid non-digestible oils, such as those described in US Patents 3,600,186 to Mattson; issued on August 17, 1971 and 4,005,195 and 4,005,196 to Jadacek et al; both issued on January 25, 1977, which are incorporated herein by reference, or mixtures of digestible or non-digestible liquid oils with solid polyol polyesters such as those described in U.S. Patent 4,797,300 to Jandacek; Issued on January 10, 1989; U.S. Patents 5,306,514 and 5,306,516 and 5,306,515 to Letton; all issued on April 26, 1994, which are incorporated herein by reference, and acetoglyceride esters, alkyl esters, alkenyl esters, lanolin and its derivatives, milk triglycerides, wax esters, beeswax derivatives , esterales, phospholipids and mixtures thereof. Grade acids, fatty acid soaps and water soluble polyols are specifically excluded from our definition of a lipophilic skin moisturizing agent. Oils and waxes of hydrocarbon: Some examples are petrolatum, microcrystalline waxes of mineral oil, polyalkenes, (hydrogenated and non-hydrogenated polybutene and polydecene), paraffin, wax, ozokerite, polyethylene and peridrosqualene. Hydrogenated and non-hydrogenated high molecular weight petrolatum and polybutene mixtures in which the ratio of petrolatum to polybutene is in the range of 90:10 to 40:60 are also suitable for use as the lipid skin wetting agent in the present compositions . Silicone Oils: Some examples are dimethicone copolyol, dimethyl polysiloxane, diethyl polysiloxane, high molecular weight dimethicone, mixed C 1 -C 30 alkyl polysiloxane, phenyl dimethicone, dimethiconol and mixtures thereof. More preferred are the non-volatile silicones selected from dimethicone, dimethiconol, mixed C 1 -C 30 alkyl polysiloxane, and mixtures thereof. Non-limiting examples of silicones useful herein are described in U.S. Patent No. 5,01,1681 to Ciotti et al., Issued April 30, 1991, which is incorporated by reference. Di- and Tri-glycerides: Some examples are castor oil, soybean oil, derived soybean oils such as maleated soybean oil, sunflower oil, cottonseed oil, corn oil, hazelnut oil, peanut oil, olive oil, cod liver oil, almond oil, avocado oil, palm oil and sesame oil, vegetable oils and vegetable oil derivatives; coconut oil and derived coconut oil, cottonseed oil and derived cottonseed oil, jojoba oil, cocoa butter, and the like. The acetoglyceride esters are used and one example is acetylated monoglycerides. Lanolin and its derivatives are preferred and some examples are lanolin, lanolin oil, lanolin wax, lanolin alcohols, lanolin fatty acids, isopropyl lanolate, acetylated lanolin, acetylated lanolin alcohols, lanolin alcohol linoleate, alcohol riconeleate of lanolin. It is most preferred when at least 75% of the lipophilic skin conditioning agent consists of lipids selected from the group consisting of: petrolatum, mixtures of petrolatum and high molecular weight polybutene, mineral oil, liquid non-digestible oils (octaesters of cottonseed sucrose) liquid) or mixtures of liquid digestible or non-digestible oils with solid polyol polyesters (for example sucrose octaesters prepared from C22 fatty acids) in which the ratio of digestible or non-digestible liquid oil to solid polyol polyester is in the scale from 96: 4 to 80:20, hydrogenated or non-hydrogenated polybutene, microcrystalline wax, polylakene, paraffin, waxen, ozokerite, polyethylene, perhydrosqualene; dimethicones, alkyl siloxane, polymethylsiloxane, methylphenylpolysiloxane and mixtures thereof. When as a mixture of petrolatum and other lipids is used, the ratio of petrolatum to the other selected lipids (polybutene or hydrogenated or non-hydrogenated polydecene or mineral oil) is preferably from 10: 1 to 1: 2., more preferably from 5: 1 to 1: 1. Stabilizers When a lipophilic skin moisturizing agent is used as the softness improver in the present antimicrobial compositions, a stabilizer may also be included at a level in the range of 0.1% 10%, preferably from 0.1% to 8%, more preferably from 0.1% to 5% by weight of the non-rinsing antimicrobial composition. The stabilizer is used to form a crystallizing stabilizing network in the liquid composition which prevents the drops of the lipophilic skin wetting agent from coalescing and separating the phase in the product. The network exhibits viscosity recovery that depends on the time after the shear (for example, thixotropy). The stabilizers used herein are not surfactants. The stabilizers provide improved shelf stability and tension, but allow the liquid personal cleansing composition to separate in the foaming, and thus provide for the increased deposition of the lipophilic skin moisturizing agent in the skin. The above is particularly true when the cleaning emulsions of the present invention are used in conjunction with an increase in sponge with polymer diamond mesh as described in Campagnoli; patent of E: U.A.
,144,744; Issued on September 8, 1992, incorporated herein by reference. In one embodiment of the present invention, the stabilizer employed is the personal cleansing compositions herein comprising a crystalline, hydroxyl-containing stabilizer said stabilizer can be a fatty acid containing hydroxyl, fatty ester or fatty soap in the substances similar to the Wax insoluble in water or similar.
The crystalline, hydroxy-containing stabilizer is selected from the group consisting of:
where
OR
R2 is R1 or H R3 is R1 or H R is alkyl of Co-20 R5 is alkyl of Co-20, Re is alkyl of Co-20 R4 + R5 + W% - C10-22 and where 1 = x + y < 4;
(I)
OR
II R7-c-OM
where
R7 is -F ^ (CHIH) xR5 (CHOH) and R6 M is Na +, k + or Mg ++, or H; and iii) mixing thereof. Some preferred hydroxyl-containing stabilizers include 12-hydroxystearic acid, 9-10-hydroxystearic acid, tri- 9, 10-dihydroxystearin and tri-12-hydroxystearin (hydrogenated resin oil is mostly tri-12-Hydroxystearin). Tri-12-hydroxystearin is most preferred for use in the emulsion compositions herein. When such crystalline, hydroxyl-containing stabilizers are used in the personal cleansing compositions herein they are typically present from about 0.1% to 10%, preferably from 0.1% to 8%, more preferably from 0.1% about 5% of the liquid personal cleansing compositions. The stabilizer is insoluble in water under an environment close to environmental conditions. Alternatively, the stabilizer employed in the personal cleansing compositions herein may comprise a polymeric thickener. When polymeric thickeners are like the stabilizer in personal cleansing compositions herein, typically it is included in an amount of about 0.1% about 5%, preferably about 0.3% about 3% by weight. the composition. The polymeric thickener is preferably an anionic, nonionic, cationic or hydrophobically modifying polymer selected from the group consisting of cationic polysaccharides of the cationic guar gum class with molecular weights of 1,000 to 3,000,000, anionic homopolymers, cationic and nonionic derivatives of acrylic and / or methacrylic acid, anionic, cationic and nonionic cellulose resins, cationic copolymers of dimethylalkylmonium chloride, acrylic acid, cationic homopolymers of dimethylalkylammonium chloride, cationic polyalkylene and ethoxypolyalkylene, polyethylene glycol of molecular weight from 100,000 to 4,000,000 , and mixtures thereof. Preferably, the polymer is selected from the group consisting of sodium polyacrylate, hydroxyethylcellulose, cetylhydroxyethylcellulose, and polyquaternium 10. Alternatively, the stabilizer employed in personal cleansing compositions herein may comprise fatty acid esters of C 10 -C 22 ethylene glycol. . The C10-C22 ethylene glycol fatty acid esters can also be desirably used in combination with the polymeric thickeners described above. The ester is preferably a diester, more preferably a C 14 -C 18 diester, more preferably ethylene glycol distearate. When the C10-C22 ethylene glycol fatty acid esters are used as the stabilizer in the personal cleansing compositions herein, typically about 3% are present around 10%, preferably about 5% around 8%, more preferably about 6% about 8% of the personal cleansing compositions. Another class of stabilizer that can be employed in the personal cleansing compositions of the present invention comprises dispersed amorphous silica selected from the group consisting of fumed silica and precipitated silica and mixtures thereof. As used herein, the term "dispersed amorphous silica" refers to small silica, finely divided non-crystalline having an average agglomerated particle size of less than 100 microns. Fuming silica, which is also known as ground silica, is produced by the hydrolysis of the vapor phase of silicon tetrachloride in a hydrogen-oxygen flame. It is believed that the combustion process creates silicon dioxide molecules that condense to form particles. The particles collide, adhere and concretize together. The result of this procedure is a three-dimensional branched chain aggregate. Once the aggregate cools below the melting point of the silica, which is about 1710 ° C, additional collisions result in the mechanical entanglement of the chains to form agglomerates. The precipitated silicas and the silica gels are generally made in aqueous solution. See, Cabot Tehcnical Data Pamphiet TD-100 entitled "CAB-O-SIL® Untreated Furnace Silica Properties and Functions", October 1993, and Cabot Technical Dat Pamphiet TD-104 entitled "CABO-SIL® Funded Silica in Cosmetic and Personal Care Products ", March 1992, both of which are incorporated herein by reference. The fumed silica preferably has an average agglomerate particle size on the scale of 0.1 micron to 100 micron, preferably 1 micron to 50 micron, and more preferably 10 micron to 30 micron. The agglomerates are composed of aggregates having an average particle size in the range of 0.01 microns to 15 microns, preferably 0.05 microns to 10 microns, more preferably 0.1 microns to 5 microns and more preferably 0.2 microns to 0.3 microns. The silica preferably has a surface area greater than 50 sq. m / gram, more preferably greater than 130 m2 / gram, more preferably greater than 180 m2 / gram. When amorphous silicas are used as the stabilizer herein, they are typically included in the non-rinsing compositions at levels on the scale of from about 0.1% to about 10%, preferably from about 0.25% to about 8%, more preferably from around 0.5% to around 5%. A fourth class of stabilizer that can be used in the non-rinsing antimicrobial compositions of the present invention consists of dispersed smectite clay selected from the group consisting of bentonite and ectorite and mixtures thereof. Bentonite is a colloidal aluminum clay sulfate. See Merck Index, Eleventh Edition, 1989, entry 1062, p. 164, which is incorporated by reference. Ectorite is a clay that contains sodium, magnesium, lithium, silica, oxygen, hydrogen and fluorine. See Merck Index, eleveth Edition, 1989, entry 4538, p. 729, which is incorporated herein by reference. When smectite clay is used as the stabilizer in the non-rinsing compositions of the present invention, it is typically included in amounts ranging from about 0.1% to about 10%, preferably from about 0.25% to about 8%, and more preferably from about 0.5% to about 5%. Other known stabilizers, such as fatty acids and fatty alcohols, can also be used in the present compositions. Palmitic acid and lauric acid are especially preferred for use herein.
F. Water The rinsing antimicrobial cleansing compositions of the present invention comprise from about 35% to about 88.8%, preferably from about 45% to about 80%, more preferably from about 55% to about 75%. Water. The rinsing antimicrobial cleaning compositions of the present invention have an apparent or pure viscosity of about 500 cps at about 60000 cps at 26.7 ° C, preferably at 5000 to 3000 cps. The term "viscosity", as used herein, refers to viscosity as measured by a Brookfield RVTDCP with a CP-41 spinner at 1 RPM for 3 minutes, unless otherwise indicated. The "pure" viscosity is the viscosity of the undiluted liquid cleaner.
G. PREFERRED OPTIONAL INGREDIENTS Softness Enhancers In order to achieve the required smoothness of the present invention, optional ingredients may be added to improve softness to the skin. These ingredients include cationic and non-ionic polymers, co-surfactants, humectants and mixtures thereof. The polymers useful herein include polyethylene glycols, polypropylene glycols, hydrolyzed bound proteins, hydrolyzed milk proteins, hydrolyzed keratin proteins, guar hydroxypropyltrimonium chloride, polyquats, silicone polymers and mixtures thereof. Polymers, preferably cationic polymers, are preferably included in the compositions herein at a level of from about 0.1% to about 10% of the composition. Surfactant coagents useful herein include nonionic surfactants such as the Genapol® 24 series of ethoxylated alcohols, POE (20) sorbitan monooleate (Tween® 80), polyethylene glycol cocoate and Pluronic® propylene oxide / ethylene oxide block polymers. , and amphoteric surfactants such as alkylbetaines and alkylsultains. Surfactant coagents are typically included in the compositions herein at a level ranging from about 2% to about 70% by weight of the anionic surfactant.
H.- Other optional ingredients The compositions of the present invention may consist of a wide range of optional ingredients. CTFA International Cosmetic Inqredient Dictionarv, Sixth Edition, 1995, which is incorporated by reference herein in its entirety, discloses a wide variety of non-limiting cosmetic and pharmaceutical ingredients commonly used in the skin care industry, which are suitable for use in the compositions of the present invention. Non-limiting examples of functional classes of ingredients are described on page 537 of this reference. Examples of those functional classes include: abrasives, anti-acne agents, cake antiforming agents, antioxidants, mixers, biological additives, volumetric agents, chelating agents, chemical additives, colorants, cosmetic astringents, cosmetic bioisides, denaturants, drug astringents, emulsifiers, external analgesics, film formers, fragrance components, humectants, oating agents, plastisers, preservatives, propellants, reducing agents, skin whitening agents, skin conditioning agents, (emollients, humectants, various, and occlusives) , skin protectants, solvents, foam boosters, hydrotropes, solubilizing agents, suspending agents (non-surfactants), sunscreen agents, ultraviolet light absorbers, and agents to increase viscosity (aqueous and non-aqueous). Examples of other functional classes of materials useful herein that are well known to one skilled in the art include solubilizing, sequestering, and keratolytic agents, and the like.
II. METHODS OF MANUFACTURING NON-RINSING ANTIMICROBIAL COMPOSITIONS The non-rinsing antimicrobial compositions of the present invention are made by art-recognized techniques for the various non-rinsing product forms. III. Methods for using the non-enisable antimicrobial composition The non-rinsable antimicrobial compositions of the present invention are useful for reducing the number of germs on the skin and controlling the dispersion of gram-negative and gram-positive bacteria over time. Typically, an appropriate or effective amount of the composition is applied to the area to be treated. Alternatively, a suitable amount of the topical composition can be applied through intermediate application to a fabric, sponge, pad, cotton ball, cushion or other application device. Generally, an effective amount of product to be used will depend on the needs and habits of use of the individual. Typical amounts of the present compositions useful for cleaning are in the range from about 0.1 mg / cm2 to about 10 mg / cm2, preferably from about 0.6 mg / cm2 to about 5 mg / cm2 of skin area to be cleaned.
ANALYTICAL TEST METHODS
Consistency (k) and shear rate (n) of lipophilic wetting agent of the skin The tension-controlled rheometer Carrimed CSL 100 was used to determine the shear rate, n, and the consistency, k, of the lipophilic wetting agent of the skin used in the present. The determination was carried out at 35 ° C with the 2 ° cone measuring system of 4 cm typically established with an arrow of 51 microns and was carried out by the programmed application of a shear stress (typically around 0.6 dynes / square centimeter around 5,000 dynes / square centimeter) for a period. If said tension results in a deformation of the sample, that is to say the measurement geometry of at least 10-4 rad / sec, then said velocity of saber would be reported as a shear rate. These data were used to create a viscosity μ Vs. Shear rate? in flow curve for the material. Said flow curve could then be molded in order to provide a mathematical expression that describes the behavior of the material within the specific limits of the shear stress and shear velocity. These results were set with the following well-accepted energy law model (see for example: Chemical Engineering, by Coulson and Richardson, Pergamon, 1982 or Transport Phenomena by Bird, Stewart and Lightfoot, Wiley, 1960):
Viscosity, μ k (? ') 1 n-l
VISCOSITY OF THE LIQUID COMPOSITION OF PERSONAL CLEANING
The Wells-Brookfield viscometer DV-II + plate model was used to determine the viscosity of the liquid personal cleansing compositions herein. The determination was carried out at 25 ° C with the cone measurement system of 2.4 cm ° (Spindle CP-41) with a gap of 0.013 mm between the two small pins in the respective cone and plate. The measurement was carried out by injecting 0.5 ml of the sample that was to be analyzed between the cone and the plate and the rotation of the cone at a fixed speed of 1 rpm. The resistance to rotation of the cone produced a torque that is proportional to the shear stress of the liquid sample. The amount of torque was read and computed by the discometer in units of absolute centipoises (mPa's) based on the geometric constants of the cone, the rotation speed, and the tension related to the torque.
EXAMPLES
The following examples further describe and demonstrate embodiments within the scope of the present invention. In the following examples, all the ingredients were enlisted at an active level. The examples are given only for the purpose of illustration and are not limited to the present invention, just as many variations thereof are possible without departing from the spirit and scope of the invention. The ingredients are identified by the chemical name or CTFA.
Procedure to make hand soaps and gels for shower bath
1. - Examples 1 and 2 of hand soap and examples 2 and 3 of gel for shower bath All the ingredients except petrolatum, active and perfume and heat were added to the point necessary for the fusion of the stabilizer (approximately 87.7 ° C for trihydroxystearin). The cooling was below 46.1 ° C and active, petrolatum and perfume were added. The final pH was adjusted using NaOH or salt regulated in its pH. The remaining water was added to complete the product. 2. Example 1 shower gel for shower. Wetting oils and surfactant coagents and heat ingredients were added at 54.4-60 ° C until dissolved. In another container, primary surfactants, acid, pH regulated salt, preservatives, viscosity detergent builder (salt) and polymer were added. Heat was added at 54.4-60 ° C until dissolved. The mixtures were combined (no single mixture was used if oils were not present), when both were found at 54.4-60 ° C then cooling was started. When the mixture was below 46.1 ° C, antibacterial active and perfume were added. The final pH was adjusted using NaOH or salt regulated in its remaining pH. The remaining water was added to complete the product.
Claims (5)
1. - A rinsing antimicrobial cleaning composition comprising: a. from 0.1% to 1% of an antimicrobial active; b. from 8% to 18% of an anionic surfactant; c. from 2% to 12% of a proton donor agent; d. from 1% to 30% of a lipophilic skin moisturizing agent; and. from 0.1% to 4% of a stabilizer; and f. from 35% to 88.8% water; characterized in that at least 67% of the anionic surfactant comprises a mixture of class A surfactants and class C surfactants and wherein the weight ratio of the class A surfactants to class C surfactants varies from 5: 1. to 1: 2 and where the composition is adjusted to a pH of 3.5 to 4.5.
2. A rinsing antimicrobial cleaning composition comprising: a. from 0.1% to 1% of an antimicrobial active; b. from 8% to 18% of an anionic surfactant; c. from 0.15% to 2% salicylic acid; d. from 1% to 30% of a lipophilic skin moisturizing agent; and. from 0.1% to 4% of a stabilizer; and f. from 45% to 90.65% water; further characterized in that at least 67% of the anionic surfactant comprises a mixture of class A surfactants and class C surfactants wherein the weight ratio of the class A surfactants to class C surfactants varies from 5: 1. to 1: 2 and where the composition is adjusted to a pH of 3.0 to 5.5.
3. The rinsing antimicrobial cleaning composition according to any of the preceding claims, further characterized in that the antimicrobial active comprises Triclosan®.
4. A rinsable antimicrobial cleaning composition according to any of the preceding claims further comprising from 0.1% to 10% of a polymer selected from the group consisting of cationic polymers, non-ionic polymers and mixtures thereof.
5. A rinsing antimicrobial cleaning composition according to any of the preceding claims which additionally comprises from 20% to 70% by weight of the anionic surfactant of the mildness enhancing surfactant coagent selected from the group consisting of betaines, lauroamfoacetate and mixtures thereof. same. 6 .- The rinsing antimicrobial cleaning composition according to any of the preceding claims, further characterized in that the proton donor is an organic acid that has a biological activity index, Z, greater than 0.75. 7. The rinsing antimicrobial cleaning composition according to any of the preceding claims, further characterized in that the ratio of the amount of non-anionic surfactants to the amount of anionic surfactant is less than 1: 1. 8. The rinsing antimicrobial cleaning composition according to any of the preceding claims, further characterized in that the lipophilic wetting agent of the skin comprises petrolatum. 9. The rinsing antimicrobial cleaning composition according to any of the preceding claims, further characterized in that the stabilizer comprises 0.1% to 1.0% of crystalline tri-12-hydroxystearin and 0.5% to 2.0% of a stabilizer selected from the group that It consists of lauric acid, lauric alcohol and mixtures thereof. 10. A method for providing residual effectiveness against Gram-negative bacteria comprising the use of a safe and effective amount of a composition according to any of the preceding claims on human skin. 1. The method for treating acne comprising the use of a safe and effective amount of the composition according to any of the preceding claims on human skin.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08869117 | 1997-06-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA99011318A true MXPA99011318A (en) | 2001-05-17 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6190674B1 (en) | Liquid antimicrobial cleansing compositions | |
US6210695B1 (en) | Leave-on antimicrobial compositions | |
US6258368B1 (en) | Antimicrobial wipes | |
US6106851A (en) | Mild, rinse-off antimicrobial liquid cleansing compositions containing salicyclic acid | |
US6113933A (en) | Mild, rinse-off antimicrobial liquid cleansing compositions containing acidic surfactants | |
US6451333B1 (en) | Mild, rinse-off antimicrobial liquid cleansing compositions | |
US6190675B1 (en) | Mild, rinse-off antimicrobial liquid cleansing compositions which provide improved residual benefit versus gram positive bacteria | |
US6214363B1 (en) | Liquid antimicrobial cleansing compositions which provide residual benefit versus gram negative bacteria | |
MXPA01010370A (en) | Antimicrobial wipes. | |
MXPA01010371A (en) | Antimicrobial wipes which provide improved immediate germ reduction. | |
MXPA01010372A (en) | Antimicrobial. | |
EP1019018A1 (en) | Mild, rinse-off antimicrobial liquid cleansing compositions | |
WO1998055095A1 (en) | Liquid antimicrobial cleansing compositions which provide residual benefit versus gram negative bacteria | |
MXPA99011318A (en) | Liquid antimicrobial cleansing compositions | |
MXPA99011374A (en) | Leave-on antimicrobial compositions | |
MXPA99011308A (en) | Mild, rinse-off antimicrobial liquid cleansing compositions containing salicylic acid | |
MXPA99011303A (en) | Mild, rinse-off antimicrobial liquid cleansing compositions containing acidic surfactants | |
MXPA99011319A (en) | Liquid antimicrobial cleansing compositions which provide residual benefit versus gram negative bacteria | |
MXPA99011372A (en) | Antimicrobial wipes | |
MXPA99011324A (en) | Mild, rinse-off antimicrobial liquid cleansing compositions | |
MXPA99011307A (en) | Mild, rinse-off antimicrobial liquid cleansing compositions | |
MXPA99011300A (en) | Mild, leave-on antimicrobial compositions | |
MXPA99011309A (en) | Mild, antimicrobial wipes | |
CZ425499A3 (en) | Topic antimicrobial preparations |